Collate raised a $95 million Series A to expand its AI platform for regulated life sciences workflows.
- Amount
- $95M
- Stage
- Series A
- Announced
- 7 June 2026
- Lead
- Redpoint Ventures
- Other investors
- First Round Capital, CRV, Conviction, Y Combinator
- Use of funds
- scale its engineering capacity, accelerate its product development timeline, and expand enterprise sales across international pharmaceutical and medical device corporations.
- Total raised
- $125M to date
- Valuation
- $1B
- Checked
- Amount and date checked against the press source